Followers | 20 |
Posts | 5350 |
Boards Moderated | 0 |
Alias Born | 01/04/2012 |
Saturday, June 10, 2017 11:58:22 AM
According to this article you would need to use 100 times the minimum dosage of Libigel to generate the same levels of potential transference generated by males using their minimum dosage. Safety concerns were addressed under the FDA SPA which gave them a path towards approval.
Transdermal testosterone gels were introduced in the U.S. in 2000. Two gels are approved in the U.S. for men: AndroGel and Testim (1%). These topically applied products are a favorable and popular mode of testosterone replacement therapy. The usual starting dose for testosterone gels in men is 50 to 60 mg per day. Survey data on the prescribing of testosterone by U.S. physicians in 2009 found that approximately 4 million prescriptions for estrogen/androgen oral medications, compounded testosterone, or brand testosterone approved for use in men were written off-label for women.3 Since the commercially available dosages are too strong for women, female patients typically are treated with testosterone compounded at a dosage of 0.5 to 2 mg per day.
https://www.uspharmacist.com/article/androgen-therapy-in-women
Personally I see Abbvie co-promoting on Libigel under a new name since it will do more than just treat HSDD. If ANIP secures the patent for CV and Breast Cancer reduction, Abbvie will buyout ANIP.
JMHO
Recent ANIP News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 11:09:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 10:55:18 AM
- ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance • GlobeNewswire Inc. • 05/10/2024 10:50:00 AM
- ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences • GlobeNewswire Inc. • 05/01/2024 08:30:00 PM
- ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
- ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension • GlobeNewswire Inc. • 04/09/2024 10:50:00 AM
- ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis • GlobeNewswire Inc. • 04/04/2024 10:50:00 AM
- ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium • GlobeNewswire Inc. • 04/03/2024 10:50:00 AM
- ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP • GlobeNewswire Inc. • 03/27/2024 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:25:12 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 10:59:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:26:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:42:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:21:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:16:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:11:59 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:05:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 10:58:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 10:31:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:29:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:24:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 10:00:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 12:18:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:18:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:12:45 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM